show index hide index
In Évreux, the University Hospital Center stands out thanks to a major technological advance in the detection of skin cancers. With one of only two machines present in France, the Vectra uses artificial intelligence to map skin lesions. This high-tech approach, combining dermatological imaging and advanced algorithms, aims to improve the early detection of melanomas. The integration of this innovation allows the center to optimize screening in the region, thus positively influencing the diagnoses and care provided to patients.
In Évreux, a major advance is being made in the field of public health thanks to the integration ofartificial intelligence in the detection of skin cancers. The local University Hospital (CHU) recently introduced a cutting-edge machine capable of effectively detecting skin lesions, which represents a true technological revolution with only two examples currently available in France. Here’s how this technology works and the implications it may have for early diagnosis of melanoma.
The Vectra: an innovation in the service of health
At the heart of this advance is the high-tech machine, called Vectra, which uses a combination of advanced imaging and artificial intelligence to identify skin abnormalities. The high-definition dermatological scanner available at Évreux University Hospital not only allows you to photograph the entire body, but also to analyze each mole and skin lesion in depth.
How Vectra technology works
The machine captures precise images of skin surfaces and uses artificial intelligence algorithms to map the characteristics of moles. It then determines the severity of potential lesions, thus facilitating clinical decisions for dermatologists. This process significantly reduces diagnostic time, with the ability to detect anomalies in as little as 30 seconds.
The application of artificial intelligence in diagnosis
The integration of artificial intelligence-based technologies in skin cancer screening aims to compensate for the limitations of traditional visual examination and dermatoscopy. By optimizing diagnostic accuracy from the earliest stages, AI contributes to faster and more efficient patient care, increasing survival rates.
Évreux, a center of excellence in dermatology
Thanks to the presence of this cutting-edge technology, Évreux positions itself as a reference center for skin cancer screening. The center is not only one of two sites in France equipped with Vectra, but it also aims to become a key player in research and improvement of skin cancer detection processes.
Potential impacts for the department
Located in a department where cases of melanoma are on the rise, the Évreux University Hospital, thanks to the Vectra machine, offers a significant contribution to improving dermatological care. By optimizing access to rapid and early diagnosis, this technology could also reduce the burden of invasive treatments by reducing the number of diseases detected at advanced stages.
